A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PAP / prostatic acid phosphatase

[Related PubMed/MEDLINE]
Total Number of Papers: 665
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PAP  (>> Co-occurring Abbreviation)
Long Form:   prostatic acid phosphatase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under hypoxia. A3AR, GBM, GSCs
2019 Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis. mTORC1, TAG
2019 Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: metabolic and inflammatory disorders. ---
2019 Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase. PCa
2019 Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP? HR, PCa, SEER, TNM
2019 Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-T alone in patients with metastatic castrate resistant prostate cancer. APC, mCRPC, PFS, RT, TNC
2019 To absorb fat - supersize my lipid droplets. TAG
2019 Treatment with methyl-beta-cyclodextrin prevents mechanical allodynia in resiniferatoxin neuropathy in a mouse model. MbetaC, RTX, TRPV1
2018 Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival. CTL, mCRPC, OS
10  2018 Assessment of the Sensitizing Potential of Proteins in BALB/c Mice: Comparison of Three Protocols of Intraperitoneal Sensitization. CMP, i.p, OVA
11  2018 ATP metabolizing enzymes ENPP1, 2 and 3 are localized in sensory neurons of rat dorsal root ganglion. DRG, ENPPs, ENT, P2Rs
12  2018 Chronic exposure to microcystin-leucine-arginine promoted proliferation of prostate epithelial cells resulting in benign prostatic hyperplasia. FOXM1, MC-LR, MCs, PSA
13  2018 Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer. ---
14  2018 Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy. A1Rs, DRG, i.t, RTX, TRPV1
15  2018 Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming. ---
16  2018 Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine. mCRPC
17  2018 Semen-derived amyloidogenic peptides-Key players of HIV infection. IDPs, SEVI
18  2018 Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers. CRPC, HLA, PPV, PSA, PSMA, TAA, UC
19  2017 Brazilin Inhibits Prostatic Acidic Phosphatase Fibrillogenesis and Decreases its Cytotoxicity. SEVI
20  2017 Characterization of phosphatidic acid phosphatase activity in the oleaginous yeast Yarrowia lipolytica and its role in lipid biosynthesis. NEM, TAG
21  2017 Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro. GM-CSF, mCRPC, TAA
22  2017 Expression of a Human Prostatic Acid Phosphatase (PAP)-IgM Fc Fusion Protein in Plants Using In vitro Tissue Subculture. Fc
23  2017 How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage. AGPAT, DGAT, GPAT, TAG
24  2017 Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival. HMECs, TNBC
25  2017 Normal human adipose tissue functions and differentiation in patients with biallelic LPIN1 inactivating mutations. ---
26  2017 Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer. IgG, IPI, mCRPC, SIP-T
27  2017 Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers. BMI, Ca, CgA, GS, PSA, PTH, ROC
28  2017 Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination. ---
29  2017 Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1. AFLD, HCC, SIRT1
30  2017 [Clinicopathological features of primary seminal vesicle adenocarcinoma: A report of 4 cases and review of the literature]. CA125, CK20, PSA, SVAC
31  2016 Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and Borderline High Prostate-Specific Antigen: A Pilot Study. PSA
32  2016 Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma. AMACR, GATA3, PAC, PSA, PSMA, UC
33  2016 EXPRESS: NGF-trkA signaling modulates the analgesic effects of prostatic acid phosphatase in resiniferatoxin-induced neuropathy. 4-MC, ATF3, NGF, RTX
34  2016 Expression of Prostatic Acid Phosphatase in Rat Circumvallate Papillae. NT5E
35  2016 Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer. AMACR, PCa, PCA3, PSA
36  2016 Intramolecular diffusion controls aggregation of the PAPf39 peptide. ---
37  2016 Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases. OB, OPG, PCa, RANK, RANKL
38  2016 Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase. NETs, PDC
39  2016 Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycle. TMPAP
40  2016 Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels. ---
41  2016 XB130 is overexpressed in prostate cancer and involved in cell growth and invasion. fPSA, PSA
42  2015 A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection. CD, EP2, TEM, ThT
43  2015 A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment. FDA, GM-CSF, IL-2, PSA, SGE
44  2015 Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells. CBS, CSE
45  2015 Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome. IgG, mCRPC, OS, PSA
46  2015 Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS. MRM-MS, MS
47  2015 Overexpression of a phosphatidic acid phosphatase type 2 leads to an increase in triacylglycerol production in oleaginous Rhodococcus strains. DAG, FFA, PA, PAP2, TAG
48  2015 Phosphatidic acid phosphatase and diacylglycerol acyltransferase: potential targets for metabolic engineering of microorganism oil. CDP-DAG pathway, DGAT, MI
49  2015 Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer. AAV, OVA, WT
50  2015 Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells. FY
51  2015 Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study. ---
52  2015 The effects of some tumor markers on human erythrocyte (HCA-I and HCA-II), bovine erythrocyte (BCA) and bovine lung (CA-IV) carbonic anhydrase enzyme activities in vitro. BCA, hCG
53  2014 A single low dose of cadmium exposure induces benign prostate hyperplasia like condition in rat: A novel benign prostate hyperplasia rodent model. BPH, Cd
54  2014 Beyond sipuleucel-T: immune approaches to treating prostate cancer. CRPC
55  2014 Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs. ---
56  2014 Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation. ---
57  2014 Deceased expression of prostatic acid phosphatase in primary sensory neurons after peripheral nerve injury. A1R, AMP, DRG
58  2014 Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. ---
59  2014 Effects of E/Z isomers of lycopene on experimental prostatic hyperplasia in mice. BPH, DHT
60  2014 Engineering a Streptomyces coelicolor biosynthesis pathway into Escherichia coli for high yield triglyceride production. CDW, DAG, DGAT, DgkA, TAG
61  2014 Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. ADA, AK, HPLC, NPP, NTPDase, PNP, TLC, TNAP
62  2014 Food proteins from different allergen families sensitize Balb/c mice to family-specific immune responses. LRP
63  2014 Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers. MUC1, PSA
64  2014 Label-free capacitive diagnostics: exploiting local redox probe state occupancy. ---
65  2014 Lipin 2 binds phosphatidic acid by the electrostatic hydrogen bond switch mechanism independent of phosphorylation. PA
66  2014 Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle. mTOR, PKD
67  2014 Making an avipoxvirus encoding a tumor-associated antigen and a costimulatory molecule. FPV, IL-2
68  2014 Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations. DRG
69  2014 Modeling of regulatory loops controlling galactolipid biosynthesis in the inner envelope membrane of chloroplasts. DAG, IEM, MGDG, PA
70  2014 Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. ---
71  2014 Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment. BTC, CM, CRPC, PCa
72  2014 Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancer. PSADT
73  2014 SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells. HIV, SEVI
74  2014 The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. GSCs
75  2013 An evolutionarily conserved mode of modulation of Shaw-like K⁺ channels. ---
76  2013 Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain. CIBP, DIP, DPCPX, POD, WDR
77  2013 Assaying plant phosphatidic acid phosphatase activity. DAG, PA
78  2013 Emerging roles of human prostatic Acid phosphatase. PSA
79  2013 Engineering E. coli for triglyceride accumulation through native and heterologous metabolic reactions. DGAT, LC-MS
80  2013 Fangjihuangqi tang improved lower urinary tract dysfunction in benign prostatic hyperplasia rats model. BI, BPH, DHT, FHT, IMD, MP, PI, RV, TP
81  2013 High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase. AMP
82  2013 Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. EPS
83  2013 Lipid phosphate phosphatase 3 participates in transport carrier formation and protein trafficking in the early secretory pathway. DAG
84  2013 Molecular cloning and catalytic activity of a membrane-bound prenyl diphosphate phosphatase from Croton stellatopilosus Ohba. CsPDP, GGPP
85  2013 Molecular diagnosis of prostate cancer: are we up to age? PCa, PSA
86  2013 Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection. SEVI
87  2013 Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination. ---
88  2013 Prostate Secretory Protein of 94 amino acids (PSP94) binds to prostatic acid phosphatase (PAP) in human seminal plasma. PSP94
89  2013 Proteomic identification of galectin-3 binding ligands and characterization of galectin-3 proteolytic cleavage in human prostasomes. PSA, ZAG
90  2013 Purification of prostatic acid phosphatase (PAP) for structural and functional studies. ---
91  2013 Self-delivery multifunctional anti-HIV hydrogels for sustained release. NSAID
92  2013 Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology. Ab, PCa, PSA, PSCA, PSMA, TMs
93  2013 Suppression of DS1 phosphatidic acid phosphatase confirms resistance to Ralstonia solanacearum in Nicotiana benthamiana. PA, ROS
94  2013 The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. IHC, NETs, PP
95  2013 Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. DKO, DRG, NT5E
96  2013 Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma. TMPAP
97  2012 An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma. EP, PCa
98  2012 An unusual variant of prostatic adenocarcinoma with metastasis to testis. A case report. PSA
99  2012 Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG. EGCG, HIV-1, SEVI
100  2012 Continuous and sensitive acid phosphatase assay based on a conjugated polyelectrolyte. pNPP